FDA Investigator Nikisha M Bolden
Nikisha M Bolden has conducted inspections on 202 sites in 2 countries as of 11 Mar 2020. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
202
Last Inspection Date:
11 Mar 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Colombia
FDA Investigators that have inspected at least one site in common with Nikisha M Bolden:
Adetutu M Gidado,
Alan D Centi,
Albert A Salvador,
Albert F Peacock, PhD,
Alfred Puglia,
Amanda B Athey,
Amy A Johnson,
Anastasia M Shields,
Andrew B Bevill,
Angel F Colon,
Anita R Michael,
Ann Marie Karnick,
Ann Marie Montemurro,
Anne E Johnson,
Anthony A Charity,
Aqualia L Nelson,
Arsen Karapetyan,
Audrey Thereset Uy,
Barbara A Gullick,
Beverly A Thomas,
Brandi L Garbutt,
Brandon J Brookens,
Brian D Young,
Brian S Keefer,
Burnell M Henry,
Cara M Minelli,
Carl E Lovrich,
CDR Donald Ertel,
Celeta S Coves,
Celia L Hutchinstein,
Chengru Zhu,
Christian D Lynch (CDL),
Christina K Theodorou,
Comyar Shoghi,
Cordelia J Brammer,
Craig D Zagata,
Crayton Lee,
Crystal A Harlan,
Cynthia Jim, CSO,
Cynthia White,
Daniel J Mechenbier,
Daniel T Lee,
Daniel W Johnson,
Darla J Christopher,
Dauksism,
David A Oluwo,
David A Schwartz,
David J Hafner,
Dawn C Olenjack,
Dawn D Aiello,
Dawn L Wydner,
Debra J Bennett,
Denise M Digiulio,
Denise M Visco, Investigator,
Derek S Dealy,
Destry M Sillivan,
Diana M Rand,
Diane M Gubernot,
Dino A Fiegelstock,
Don A Leeseberg,
Donald W Myrick,
Donyel M Jones,
Dr. Gang Wang, PhD,
Dr. Willie F Vann, PhD,
Dylan R Jock,
Edmund F Mrak, Jr,
Edward D Mcdonald,
Edwin L Hobbs,
Eliezar Ramos,
Elizabeth D Connell,
Emilio Z Azukwu,
Emily A Walters,
Emmanuel Obulor,
Erica L Nicoll,
Erika M Wilkerson,
Evan Tong,
Frederic W French, III,
Gayle S Lawson,
Gene D Arcy,
Gerald T O'connor,
Gerald W Kopp,
Gladys B Casper,
Hala L Selby,
Helen B Ricalde,
Jaclyn N Munsch,
Jacob M Dyer,
Jacqueline M Bowling,
Jacqueline Mdiaz Albertini,
James E Keller, PhD,
James M Mason,
James P Mcevoy,
James R Evans,
Janet Pulver,
Jason M Sluzynski,
Jeannie R Mayberry,
Jeen S Min,
Jennifer A Bazergui,
Jennifer L Custodio,
Jennifer L Schmidt,
Jennifer Macmillan,
Joan A Loreng,
Jocelyn E Massey,
Joseph Brady,
Joseph George,
Joseph L Despins, PhD,
Joseph S Fanelli,
Joseph T Dougherty,
Juanita P Versace,
Judith A Paterson,
Judy Ellen Ciaraldi,
Julianne C Mccullough,
Julie D Bringger,
Junho Pak,
Justin A Boyd,
Justin B Holder,
Katelyn Astaub Zamperini,
Kendra L Brooks,
Kenneth S Boehnen,
Kim G Campbell,
Kimberly A Dux,
Kip J Hanks,
Kish Bolden,
Kristen D Evans,
Kristina J Donohue,
Kyle D Covill,
Latorie S Jones,
Laurie A Haxel,
Laurie P Norwood,
LCDR Margaret Edi Gennaro,
Lillie M Young,
Linda M Hoover,
Linda M Ross,
Linda S Mattingly,
Lisa B Orr,
Lisa Harlan,
Lisa L Caulder,
Loretta Nemchik,
LT John M Mastalski,
LTJG Bradley E Benasutti,
LTJG Lauren N Shade,
Marc A Jackson, Jr,
Marcelo O Mangalindan, Jr,
Marion Michaelis,
Martha Sullivan Myrick,
Martin K Yau, PhD,
Matthew R Noonan,
Maureen A Wentzel,
Maxyne T Lam,
Meena Bansal Gupta, PhD,
Megan F Mclaughlin,
Megan M Lauff,
Meredith L Sheridan,
Merelynn Rhoten,
Michael A Taylor,
Michael J Herz,
Michael J Nerz,
Michael Rosner,
Michele Gottshall,
Michele L Forster, PhD,
Michele M Falchek,
Mihaly S Ligmond,
Mike M Rashti,
Minh D Phan,
Miriam Montes,
Nadia R Barreda,
Nancy L Rose,
Nancy M Espinal,
Nerizza B Guerin,
Nicole K Trudel,
Pamela M Tremarki,
Patrick J Campbell,
Paul L Bellamy,
Paula A Trost,
Paula J Perry,
Prabhu P Raju,
Rachael O Oyewole,
Raffi B Papazian,
Ramanda C Gregory,
Raymond W Brullo,
Rebecca K Olin,
Richard T Riggie,
Richard W Thornton,
Rita F Larocca Mahoney,
Robert B Shibuya, MD,
Robert M Tillman,
Robert Sausville,
Ronald A Stokes,
Ronald T Colucci,
Ronda Rloyd Jones,
Rose Ashley,
Ruben C Quintana,
Russell J Glapion,
Russell P Vandermark,
Ruth A Oni,
Sarah B Tanksley,
Sarah Forney,
Sarah K Lemin,
Sean D Duke,
Sean W Linder,
Seng Ching Hwang,
Shelley L Waring,
Solomon Yimam (SY),
Stephanie Mangigian, MS/OSH, RN,
Steven D Banks,
Steven E Kane,
Susan M Jackson,
Suzanne M Healy,
Tania E Vizcaino,
Tania Y Hall,
Teigan M Mule,
Tekalign Wondimu,
Terrance L Thomas,
Terri L Jones,
Thomas E Friel,
Timothy P Lafave,
Tina S Roecklein,
Todd J Maushart,
Tonya O Corbin,
Travis R Hunt,
Tressa T Lewis,
Vien Q Le,
Vivin George,
Vlada Matusovsky,
Wei Wang, PhD,
Whitney S Reynolds,
William C Brenneman,
Xinyi Hui,
Yessika Mashinski,
Yvonne C Wilkes
Nikisha M Bolden's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more